Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells

Neuroscience

Volumn 200, Issue , 2012, Pages 130-141

  da Fonseca, A C C ^a   Romao L ^a   Amaral, R F ^a   Assad Kahn, S ^a   Lobo, D ^a   Martins, S ^a   Marcondes de Souza, J ^a   Moura Neto, V ^a   Lima, F R S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Glioblastoma; Microglia; Migration; Proliferation; STI1

Indexed keywords

CHAPERONE; GELATINASE B; NEUTRALIZING ANTIBODY; PRION PROTEIN; STRESS INDUCIBLE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; MICROGLIA; PRIORITY JOURNAL; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HEAT-SHOCK PROTEINS; HUMANS; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROGLIA; NEURONS; PRPC PROTEINS; THYMIDINE; TIME FACTORS; TRITIUM;

EID: 84855188858     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.10.025     Document Type: Article

References (62)

1. Alliot F., Godin I., Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 1999, 117:145-152.
2. Alves T.R., Lima F.R.S., Kahn S.A., Lobo D., Dubois L.G.F., Soletti R., Borges H., Moura Neto V.M. Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sci 2011, 89(15-16):532-539.
3. Arantes C., Nomizo R., Lopes M.H., Hajj G.N., Lima F.R., Martins V.R. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia 2009, 57:1439-1449.
4. Arruda-Carvalho M., Njaine B., Silveira M.S., Linden R., Chiarini L.B. Hop/STI1 modulates retinal proliferation and cell death independent of PrPC. Biochem Biophys Res Commun 2007, 361:474-480.
5. Badie B., Schartner J.M. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 2000, 46:957-961. discussion:961-952.
6. Brown D.R., Besinger A., Herms J.W., Kretzschmar H.A. Microglial expression of the prion protein. Neuroreport 1998, 9:1425-1429.
7. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582.
8. Caetano F.A., Lopes M.H., Hajj G.N., Machado C.F., Pinto Arantes C., Magalhaes A.C., Vieira Mde P., Americo T.A., Massensini A.R., Priola S.A., Vorberg I., Gomez M.V., Linden R., Prado V.F., Martins V.R., Prado M.A. Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci 2008, 28:6691-6702.
9. Chaudhary A.K., Singh M., Bharti A.C., Asotra K., Sundaram S., Mehrotra R. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 2010, 17:10.
10. Chéret C., Gervais A., Lelli A., Colin C., Amar L., Ravassard P., Mallet J., Cumano A., Krause K.H., Mallat M. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J Neurosci 2008, 28(46):12039-12051.
11. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002, 21:3317-3326.
12. Dalmau I., Vela J.M., González B., Finsen B., Castellano B. Dynamics of microglia in the developing rat brain. J Comp Neurol 2003, 458(2):144-157.
13. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
14. Erlich R.B., Kahn S.A., Lima F.R., Muras A.G., Martins R.A., Linden R., Chiarini L.B., Martins V.R., Moura Neto V. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007, 55:1690-1698.
15. Faria J., Romão L., Martins S., Alves T., Mendes F.A., de Faria G.P., Hollanda R., Takiya C., Chimelli L., Morandi V., de Souza J.M., Abreu J.G., Moura Neto V. Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 2006, 74:562-572.
16. Ferrario A., Gomer C.J. Targeting the 90 kDa heat shock protein improves photodynamic therapy. Cancer Lett 2010, 289:188-194.
17. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., Raposo G. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004, 101:9683-9688.
18. Garden G.A., Moller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 2006, 1:127-137.
19. Ghosh A., Chaudhuri S. Microglial action in glioma: a boon turns bane. Immunol Lett 2010, 131:3-9.
20. Graeber M.B., Scheithauer B.W., Kreutzberg G.W. Microglia in brain tumors. Glia 2002, 40:252-259.
21. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394.
22. Hussain S.F., Yang D., Suki D., Aldape K., Grimm E., Heimberger A.B. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 2006, 8:261-279.
23. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
24. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol Rev 2011, 91(2):461-553.
25. Kim Y.J., Hwang S.Y., Han I.O. Insoluble matrix components of glioma cells suppress LPS-mediated iNOS/NO induction in microglia. Biochem Biophys Res Commun 2006, 347:731-738.
26. Kleihues P., Sobin L.H. World Health Organization classification of tumors. Cancer 2000, 88:2887.
27. Kupai K., Szucs G., Cseh S., Hajdu I., Csonka C., Csont T., Ferdinandy P. Matrix metalloproteinase activity assays: importance of zymography. J Pharmacol Toxicol Methods 2010, 61:205-209.
28. Landriscina M., Amoroso M.R., Piscazzi A., Esposito F. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 2010, 117:177-182.
29. Lima F.R., Arantes C.P., Muras A.G., Nomizo R., Brentani R.R., Martins V.R. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 2007, 103:2164-2176.
30. Lima F.R., Gervais A., Colin C., Izembart M., Neto V.M., Mallat M. Regulation of microglial development: a novel role for thyroid hormone. J Neurosci 2001, 21:2028-2038.
31. Linden R., Martins V.R., Prado M.A., Cammarota M., Izquierdo I., Brentani R.R. Physiology of the prion protein. Physiol Rev 2008, 88:673-728.
32. Liu Y., Shete S., Hosking F.J., Robertson L.B., Bondy M.L., Houlston R.S. New insights into susceptibility to glioma. Arch Neurol 2010, 67:275-278.
33. Lopes M.H., Hajj G.N., Muras A.G., Mancini G.L., Castro R.M., Ribeiro K.C., Brentani R.R., Linden R., Martins V.R. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 2005, 25:11330-11339.
34. Magalhães A.C., Silva J.A., Lee K.S., Martins V.R., Prado V.F., Ferguson S.S., Gomez M.V., Brentani R.R., Prado M.A. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 2002, 277(36):33311-33318.
35. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001, 15:1311-1333.
36. Mallat M., Marín-Teva J.L., Chéret C. Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 2005, 15:101-107.
37. Markovic D.S., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 2005, 64:754-762.
38. Markovic D.S., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., Sliwa M., Lehmann S., Kälin R., van Rooijen N., Holmbeck K., Heppner F.L., Kiwit J., Matyash V., Lehnardt S., Kaminska B., Glass R., Kettenmann H. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci U S A 2009, 106:12530-12535.
39. Martins V.R., Graner E., Garcia-Abreu J., de Souza S.J., Mercadante A.F., Veiga S.S., Zanata S.M., Neto V.M., Brentani R.R. Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 1997, 3:1376-1382.
40. Martins V.R., Linden R., Prado M.A., Walz R., Sakamoto A.C., Izquierdo I., Brentani R.R. Cellular prion protein: on the road for functions. FEBS Lett 2002, 512:25-28.
41. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
42. Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Prion protein biology. Cell 1998, 93:337-348.
43. Quick A., Patel D., Hadziahmetovic M., Chakravarti A., Mehta M. Current therapeutic paradigms in glioblastoma. Rev Recent Clin Trials 2010, 5:14-27.
44. Reardon D.A., Rich J.N., Friedman H.S., Bigner D.D. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 2006, 24:1253-1265.
45. Rodrigues J.C., Gonzalez G.C., Zhang L., Ibrahim G., Kelly J.J., Gustafson M.P., Lin Y., Dietz A.B., Forsyth P.A., Yong V.W., Parney I.F. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol 2010, 12(4):351-365.
46. Santuccione A., Sytnyk V., Leshchyns'ka I., Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005, 169:341-354.
47. Sliwa M., Markovic D., Gabrusiewicz K., Synowitz M., Glass R., Zawadzka M., Wesolowska A., Kettenmann H., Kaminska B. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 2007, 130:476-489.
48. Stellas D., El Hamidieh A., Patsavoudi E. Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol 2010, 11:51.
49. Streit W.J., Xue Q.S. Life and death of microglia. J Neuroimmune Pharmacol 2009, 4:371-379.
50. Sunyach C., Jen A., Deng J., Fitzgerald K.T., Frobert Y., Grassi J., McCaffrey M.W., Morris R. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 2003, 22(14):3591-3601.
51. Teodorczyk M., Martin-Villalba A. Sensing invasion: cell surface receptors driving spreading of glioblastoma. J Cell Physiol 2010, 222:1-10.
52. Théry C., Chamak B., Mallat M. Cytotoxic effect of brain macrophages on developing. Eur J Neurosci 1991, 3:1155-1164.
53. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 2005, 37:17-21.
54. Vincent B., Paitel E., Frobert Y., Lehmann S., Grassi J., Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000, 275:35612-35616.
55. Walsh N., Larkin A., Swan N., Conlon K., Dowling P., McDermott R., Clynes M. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Lett 2011, 306:180-189.
56. Watters J.J., Schartner J.M., Badie B. Microglia function in brain tumors. J Neurosci Res 2005, 81:447-455.
57. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., Franciszkiewicz K., Chouaib S., Kaminska B. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 2008, 27:918-930.
58. Wick W., Platten M., Weller M. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neuro Oncol 2001, 53:177-185.
59. Yang Y., Rao R., Shen J., Tang Y., Fiskus W., Nechtman J., Atadja P., Bhalla K. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res 2008, 68:4833-4842.
60. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.
61. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., Freitas A.R., Cabral A.L., Lee K.S., Juliano M.A., de Oliveira E., Jachieri S.G., Burlingame A., Huang L., Linden R., Brentani R.R., Martins V.R. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002, 21:3307-3316.
62. Zhao B.Q., Tejima E., Lo E.H. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007, 38:748-752.